Episode Details

Revolutionary Blood Test Detects Early-Stage Pancreatic Cancer with 88% Accuracy

Researchers have developed a groundbreaking blood test that can spot early-stage pancreatic cancer with nearly 88% accuracy. This test uses four protein markers to catch the disease before it spreads, potentially transforming how we combat one of the deadliest cancers.

Currently, pancreatic cancer is often undetected until its too late for effective treatment, as theres no standard screening test. Most cases are found at advanced stages, where survival rates are low.

The team, led by a doctor at the University of Pennsylvania, built upon earlier work with two proteins that werent reliable alone. They added two more markers found at higher levels in early cancer patients compared to healthy individuals or those with other pancreatic conditions.

In their study, they tested blood samples from 672 people, including cancer patients, healthy individuals, and those with conditions like pancreatitis. The full test accurately detected cancer over 90% of the time overall and effectively ruled out non-cancer cases.

Larger trials are planned to confirm these results. If successful, the test could screen high-risk groups, such as those with a family history or certain genetic factors, and guide who needs further scans.

Support the show
Get a discount at https://solipillow.com/discount/dnn.

Advertise on DNN
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai

View sources & latest updates
https://sources.thednn.ai/f159b39f608feb69